Effect of the Arg16Gly β <sub>2</sub> ‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study

The Arg16 allele of the rs1042713 polymorphism increases the risk of severe eosinophilic asthma and may reduce the long-term efficacy of mepolizumab, whereas the Gly16 allele appears to confer better outcomes and higher remission rates.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-09-23
DOI
https://doi.org/10.1111/all.70071
Citations
1
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of the Arg16Gly β 2 ‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study

Nunzio Crimi, Claudio Candia, Maria Pia Foschino Barbaro, Andrea Portacci et al.
1 citations
Allergy
Asthma and respiratory diseases
1.16
article

Effect of the Arg16Gly β 2 ‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study

Nunzio Crimi, Claudio Candia, Maria Pia Foschino Barbaro, Andrea Portacci, Alessandro Saglia, Carlo Vancheri, Girolamo Pelaia, Raffaele Campisi, Giulia Scioscia, Claudia Crimi, Corrado Pelaia, Santi Nolasco, Vitaliano Nicola Quaranta, Angelantonio Maglio, Giovanna Elisiana Carpagnano, Evelina Fagone, Alessandro Vatrella, Isabella Carrieri, Maria D'Amato
article en
1 citations

Abstract

The Arg16 allele of the rs1042713 polymorphism increases the risk of severe eosinophilic asthma and may reduce the long-term efficacy of mepolizumab, whereas the Gly16 allele appears to confer better outcomes and higher remission rates.

AllergyVol. 81(3)
University of Foggia (IT), University of Salerno (IT), Marconi University (IT), Magna Graecia University (IT), University of Catania (IT), Federico II University Hospital (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT)
Openalex Percentile: Top 18%
Asthma and respiratory diseases
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.